Literature DB >> 8760433

Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.

H Kohno1, T Inoue, F Tsuda, H Okamoto, Y Akahane.   

Abstract

Three clones of hepatitis B virus (HBV) DNA were propagated from sera of each of five patients with chronic hepatitis B who possessed hepatitis B surface antigen (HBsAg) and antibody to HBsAg in their serum. The clones were sequenced within the envelope gene (the preS1, preS2 regions and the S gene). Clones from four patients had various missense mutations involving codons 124-147 of the S-gene which encode amino acids in the loop structures that form the conformational, common antigenic determinant of HBsAg. Clones from three patients had Asn-130 (Gly in the wild-type), which generated a potential N-glycosylation site, Asn-Thr-Ser, spanning amino acids 130-132 of the S-gene product. In addition, clones from one patient had Arg-145 (Gly in the wild-type), which has been reported in escape mutants of HBV. One of the three clones from another patient had Ser-126 in place of lle or Thr in wild-type HBV, but the remaining two had no mutations known to affect expression of the common determinant of HBsAg. The remaining patient possessed HBsAg of subtype adr and anti-HBs specific for the w determinant. Clones from this patient did not reveal any mutations which are known to affect the common antigenic determinant of HBsAg.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760433     DOI: 10.1099/0022-1317-77-8-1825

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  The amino Acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen.

Authors:  Yongjun Tian; Yang Xu; Zhenhua Zhang; Zhongji Meng; Li Qin; Mengji Lu; Dongliang Yang
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

Review 2.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

3.  Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants.

Authors:  Olivier Lada; Yves Benhamou; Thierry Poynard; Vincent Thibault
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 4.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

5.  Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations.

Authors:  Jeong Han Kim; Young Kul Jung; Moon Kyung Joo; Ji Hoon Kim; Hyung Joon Yim; Jong-Jae Park; Jae Seon Kim; Young-Tae Bak; Jong Eun Yeon; Kwan Soo Byun
Journal:  J Korean Med Sci       Date:  2009-01-19       Impact factor: 2.153

6.  A novel nucleotide insertion in S gene of hepatitis B virus in a chronic carrier.

Authors:  Wenbin Tong; Li Sun; Jilan He; Shusen He; Fei Du
Journal:  Virol J       Date:  2010-05-22       Impact factor: 4.099

7.  HBsAg/HBsAb double positive hepatitis B virus infection model in vitro and in vivo.

Authors:  Zhenhua Zhang; Lei Li; Yongjun Tian; Jianbo Xia; Youhua Hao; Xu Li; Mengji Lu; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-10-11

8.  In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees.

Authors:  Se Ho Kim; Se Ho Kim; Han Kyu Oh; Chun Jeih Ryu; Song Yong Park; Hyo Jeong Hong
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

9.  Hepatitis B virus S gene escape mutants.

Authors:  Michael A Purdy
Journal:  Asian J Transfus Sci       Date:  2007-07

10.  An analysis of the molecular evolution of hepatitis B viral genotypes A/B/D using a Bayesian evolutionary method.

Authors:  Guangyu Xu; Chengguo Wei; Yuqi Guo; Chao Zhang; Nan Zhang; Guoqing Wang
Journal:  Virol J       Date:  2013-08-10       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.